Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal

References

• Global Tuberculosis Report-World Health Organization. Available from: https://apps.who.int/iris/bitstream/handle/10665//9789241565646-eng.pdf. Accessed 9 26, 2018
   Google Scholar
• Baqui AH, Black RE, El Arifeen S, et al. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ. 2002;325(7372):1059. doi:10.1136/bmj.325.7372.105912424162
   PubMed Web of Science ®Google Scholar
• Saha K, Rao K. Undernutrition in lepromatous leprosy. V. Severe nutritional deficit in lepromatous patients co-infected with pulmonary tuberculosis. Eur J Clin Nutr. 1989;43(2):117–128.2707215
   PubMed Web of Science ®Google Scholar
• Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect. 2012;64(6):580–588. doi:10.1016/j.jinf.2012.02.01222381459
   PubMed Web of Science ®Google Scholar
• Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6(9):1067–1082. doi:10.2217/fmb.11.8421958145
   PubMed Web of Science ®Google Scholar
• Tessema B, Beer J, Emmrich F, Sack U, Rodloff A. First-and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberculosis Lung Dis. 2012;16(6):805–811. doi:10.5588/ijtld.11.0522
   Web of Science ®Google Scholar
• Getahun M, Ameni G, Kebede A, et al. Molecular typing and drug sensitivity testing of Mycobacterium tuberculosis isolated by a community-based survey in Ethiopia. BMC Public Health. 2015;15(1):751. doi:10.1186/s12889-015-2105-726245282
   PubMed Web of Science ®Google Scholar
• Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48(7):2495–2501. doi:10.1128/JCM.00128-1020504986
   PubMed Web of Science ®Google Scholar
• Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005–1015. doi:10.1056/NEJMoa090784720825313
   PubMed Web of Science ®Google Scholar
• Hordofa MW, Adela TB. Prevalence of Refampcin mono resistant Mycobacterium tuberculosis among suspected cases attending at Yirgalem hospital. Clin Med Res. 2015;4(3):75–78. doi:10.11648/j.cmr.20150403.13
   Google Scholar
• Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015;15(1):220. doi:10.1186/s12866-015-0566-626483194
   PubMed Web of Science ®Google Scholar
• Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185. doi:10.2147/IDR.S13593528652786
   PubMed Web of Science ®Google Scholar
• Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017;10(1):8. doi:10.1186/s13104-016-2328-428057041
   PubMedGoogle Scholar
• Banda H, Harries A, Welby S, et al. Prevalence of tuberculosis in TB suspects with short duration of cough. Trans R Soc Trop Med Hyg. 1998;92(2):161–163. doi:10.1016/S0035-9203(98)90727-19764320
   PubMed Web of Science ®Google Scholar
• Sánchez-Pérez H, Flores-Hernández J, Jansá J, Caylá J, Martín-Mateo M. Pulmonary tuberculosis and associated factors in areas of high levels of poverty in Chiapas, Mexico. Int J Epidemiol. 2001;30(2):386–393. doi:10.1093/ije/30.2.38611369747
   PubMed Web of Science ®Google Scholar
• Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis. 2011;11(11):819–824. doi:10.1016/S1473-3099(11)70167-021764384
   PubMed Web of Science ®Google Scholar
• Sekadde MP, Wobudeya E, Joloba ML, et al. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. BMC Infect Dis. 2013;13(1):133. doi:10.1186/1471-2334-13-13323497044
   PubMed Web of Science ®Google Scholar
• Workalemahu B, Berg S, Tsegaye W, et al. Genotype diversity of Mycobacterium isolates from children in Jimma, Ethiopia. BMC Res Notes. 2013;6(1):352. doi:10.1186/1756-0500-6-35224007374
   PubMedGoogle Scholar
• Deribew A, Negussu N, Melaku Z, Deribe K. Investigation outcomes of tuberculosis suspects in the health centers of Addis Ababa, Ethiopia. PLoS One. 2011;6(4):e18614. doi:10.1371/journal.pone.001861421526179
   PubMed Web of Science ®Google Scholar
• Yohanes A, Abera S, Ali S. Smear positive pulmonary tuberculosis among suspected patients attending Metehara sugar factory hospital; eastern Ethiopia. Afr Health Sci. 2012;12(3):325–330. doi:10.4314/ahs.v12i3.1223382747
   PubMed Web of Science ®Google Scholar
• Gautam PB, Mishra A, Kumar S. Prevalence of rifampicin resistant mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients in eastern Uttar Pradesh: a cross sectional study. Int J Community Med Public Health. 2018;5(6):2271–2276. doi:10.18203/2394-6040.ijcmph20182039
   Google Scholar
• Berhe G, Enqueselassie F, Hailu E, et al. Population-based prevalence survey of tuberculosis in the Tigray region of Ethiopia. BMC Infect Dis. 2013;13(1):448. doi:10.1186/1471-2334-13-44824073793
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-732015507
   PubMed Web of Science ®Google Scholar
• Makamure B, Mhaka J, Makumbirofa S, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe. PLoS One. 2013;8(2):e55872. doi:10.1371/journal.pone.005587223409072
   PubMed Web of Science ®Google Scholar
• Nwadioha S, Nwokedi E, Ezema G, et al. Drug resistant Mycobacterium tuberculosis in Benue, Nigeria. Br Microbiol Res J. 2014;4(9):988–995. doi:10.9734/BMRJ/2014/9084
   Google Scholar
• Gupta A, Mathuria JP, Singh SK, Gulati AK, Anupurba S. Antitubercular drug resistance in four healthcare facilities in North India. J Health Popul Nutr. 2011;29(6):583.22283032
   PubMed Web of Science ®Google Scholar
• Nigus D, Lingerew W, Beyene B, Tamiru A, Lemma M, Melaku M. Prevalence of multi drug resistant tuberculosis among presumptive multi drug resistant tuberculosis cases in Amhara National Regional State, Ethiopia. J Mycobac Dis. 2014;4(152):2161–1068.1000152. doi:10.4172/2161-1068.1000152
   Google Scholar
• Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtjørn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi zone, Oromia regional state, Central Ethiopia. BMC Public Health. 2016;16(1):593. doi:10.1186/s12889-016-3210-y27430266
   PubMed Web of Science ®Google Scholar
• Tessema B, Beer J, Merker M, et al. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect Dis. 2013;13(1):131. doi:10.1186/1471-2334-13-13123496968
   PubMed Web of Science ®Google Scholar
• Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57–61. doi:10.1016/j.ijid.2015.08.01326327121
   PubMed Web of Science ®Google Scholar
• Adejumo OA, Olusola-Faleye B, Adepoju V, et al. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria. Afr Health Sci. 2018;18(3):472–478. doi:10.4314/ahs.v18i3.230602977
   PubMed Web of Science ®Google Scholar
• Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis. 2019;19(1):307. doi:10.1186/s12879-019-3943-130947695
   PubMed Web of Science ®Google Scholar
• Toungoussova O, Caugant D, Sandven P, Mariandyshev A, Bjune G. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberculosis Lung Dis. 2002;6(5):406–414.
   PubMed Web of Science ®Google Scholar
• Lockman S, Kruuner A, Binkin NJ, et al. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Clin Infect Dis. 2001;32(3):373–380. doi:10.1086/31848911170944
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. Int J Infect Dis. 2014;22:83–86. doi:10.1016/j.ijid.2013.12.01524556164
   PubMed Web of Science ®Google Scholar
• Sethi S, Mewara A, Dhatwalia SK, et al. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. BMC Infect Dis. 2013;13(1):137. doi:10.1186/1471-2334-13-13723497169
   PubMed Web of Science ®Google Scholar
• Espinal MA, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberculosis Lung Dis. 2001;5(10):887–893.
   PubMed Web of Science ®Google Scholar